Satellite view of Earth at night with illuminated cities across continents.

Access Navigate

We help biopharma teams navigate access challenges in Payer Value, Price, Reimbursement and Patient Access to achieve clinical and commercial success.

01
Navigate Access

Have you planned for

Value

What is the Payer Value of this indication or drug?

Value Drivers
Unmet Need
Clinical Trial Design
Real World Data
Evidence Generation
Health Economics
Budget Impact
Cost-effectiveness
Value Dossier
Value Messages
Objection Handler FAQ

Building value for payers
Price strategy

Price

What is the right Price for this indication or drug?

Price Benchmarks
Price across Indications
Price across Lifecycle
Gross-To-Net (GTN)
Discounts, Rebates
Contracting
Price Erosion
Price Strategy

Access

Will Payers reimburse?
Will Patients have access ?

Restrictions beyond label
Covered Lives
Utilization Management
Prior Authorization
Preferred Tier, Step Therapy
Approval, Rejection
Abandonment
Affordability, Copay

Patient access to medicine
02
Planning

Each step of the way

Early Clinical Development

Target Product Profile (TPP)

Indication: Is this indication commercially viable? What is the Price and Access potential of this indication? What are likely Payer price comparators and analogs at the time of approval?

Target Product Profile: What Payer requirements are needed for market access, price and reimbursement? Does the TPP support optimal price and reimbursement for commercial success and patient access?

A dart striking the bullseye on a dartboard, showcasing precision and accuracy.
Close-up of a scientist handling samples in a lab with various chemicals and glassware.
Phase 2 and 3

Clinical Trials

Clinical Trial Design: What are the Payer requirements required in phase 2 and 3 clinical trial design to support optimal market access, price and reimbursement?

Evidence Generation: Would the TPP, clinical and real world evidence package support the target price, reimbursement and patient access? Are there any evidence gaps?

Launch & Indication Expansion

Launch Market Access &
Payer Value Platform

What market access deliverables are needed for launch sucess?
Market Access Plan: Develop Access strategy, Launch sequence optimization 
Commercial Strategy : Optimize Market Access, Pricing & Reimbursement for launch indication and follow on indications?
Pricing: Develop Pricing policy & corridors, Price governance & exceptions

What payer value material is needed?
Payer Communication: Develop Value Story & Payer Message Testing
Dossiers: Develop AMCP Dossier & Global Value Dossier
HTA: Submission planning, Negotiation training
Evidence generation: Build RWE, HEOR to meet payer requirements
Value Proposition messages: Develop, refine and test with key customer segments (payers, PBMs, specialty pharmacies).
External engagement: Develop strategy & Execute Policy shaping, Patient advocacy, Patient access programs, Affordability & hub services

Close-up of stacked colorful pastel chalks, showcasing a vibrant array of colors and textures.
03
About

Our Team

Access Navigate is a specialty consulting advisory helping biopharma healthcare teams to build payer value, navigate market access, accelerate price and reimbursement outcomes through agile, senior-led partnership.

We provide solutions with deep expertise, speed and precision.

Team. We specialize in Value & Access, Pricing & Reimbursement, Innovative Partnership, Policy & External Engagement, combining strategic insight with smart execution. Every engagement is led by senior advisors, with deep expertise, speed, and precision—without layers or inefficiency.

Deliverables. We co-create with your teams to build value & access strategies, innovate solutions, run payer insights research, support BD and portfolio investments, develop price and access forecasts, value dossiers, value story communications, objection handlers FAQs, and payer engagement tools that drive impact.

Lifecycle. From early pipeline to phase 2/3 trial design, launch planning, post-launch growth, multi-indication expansion, and LOE planning, Access Navigate delivers integrated solutions that drive global strategy and local execution.

Expertise. Across Oncology, Rare Diseases, Cardiometabolic, Immunology, Neurology and more. Geographies cover US, EU5, China, Japan, Asia-Pacific, Middle East, Africa, Latin America, and emerging markets. Our network of experts provide answers to the most complex questions.

Partnership. A trusted thought partner to global, regional, and country teams, we help leaders influence across organizations to align vision, strategy and deliver measurable results. Our cross-disciplinary mindset catalyzes innovative, pragmatic access solutions to win and keep ahead in a fast-changing payer landscape.

Request for Proposal at Iniquiry@AccessNavG.com. We match and outperform any comparable proposal—delivering results 120% to 150% faster, 120% to 180% higher quality, achieving 200% more value. Flexible scope and pricing tailored to your business needs.

Access Navigate – agile partnership, senior expertise, accelerated impact.

04
Services

We deliver

Partner us

Samuel.Ang@AccessNavG.com
We look forward to working with you!